信息搜索
信息关键字:药
 
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·股票行情快报:恩威医药(301331)11月17日主力资金净买入100.10万元2023-11-18 7:04:19
·股票行情快报:北陆药业(300016)11月17日主力资金净卖出71.97万元2023-11-18 6:51:55
·股票行情快报:华东医药(000963)11月17日主力资金净买入917.77万元2023-11-18 4:33:03
·股票行情快报:双成药业(002693)11月17日主力资金净买入146.76万元2023-11-18 4:24:35
·医药生物行业专题:白癜风:百亿量级空白市场,国内研发格局极佳2023-11-18 2:06:12
·“药明系”上市公司再添一员 药明合联登陆港交所首日涨超35%2023-11-18 1:39:59
·168种药品进入国家医保谈判竞价环节 2023年国家医保药品谈判结果或于12月公布2023-11-17 21:58:53
·A股“铁公鸡”曝光,最长29年未分红送转!百花医药融资是分红的465倍2023-11-17 21:46:27
·罗欣药业:替戈拉生片新适应症获得《药品注册证书》2023-11-17 21:38:23
·迪哲医药:国际权威期刊《药物》发表舒沃哲?获批信息和关键数据综述2023-11-17 21:30:03
·恒瑞医药:耗资624662597.16元回购股份14112323股2023-11-17 20:43:53
·迪哲医药:国际权威期刊发表舒沃哲获批信息和关键数据综述2023-11-17 20:26:50
·华北制药:全资子公司收到氨苄西林《化学原料药上市申请批准通知书》2023-11-17 20:06:31
·景峰医药:公司预重整债权申报通知2023-11-17 19:14:46
·华北制药:下属公司获得氨苄西林《化学原料药上市申请批准通知书》2023-11-17 19:02:09
·制剂产品出海实现零突破 苑东生物盐酸纳美芬注射液获美国FDA药品注册批准2023-11-17 18:49:33
·AD诊断行业研究报告(一):阿尔兹海默症新药即将在国内获批上市,如何判断AD诊断行业空间?2023-11-17 18:28:11
·宣泰医药:公司产品中选第九批国家组织药品集中带量采购2023-11-17 18:20:53
·药明康德、理想汽车将加入香港恒生指数2023-11-17 18:05:53
·华纳药厂:ZY022项目已经完成临床前研究2023-11-17 16:24:34

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]